BamSEC and AlphaSense Join Forces
Learn More

CERo Therapeutics Holdings Inc.

NASDAQ: CERO    
Share price (12/23/24): $0.05    
Market cap (12/23/24): $7.591 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from S-1 15 pages Description of Securities
12/34/56
EX-4.1
from 8-K 28 pages CERo Therapeutics Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.5
from 10-K 11 pages Description of Securities
12/34/56
EX-4.5
from 8-K/A 11 pages Description of Securities
12/34/56
EX-4.3
from 8-K/A 20 pages CERo Therapeutics Holdings, Inc. (F/K/a Phoenix Biotech Acquisition Corp.) Warrant to Purchase Series a Convertible Preferred Stock
12/34/56
EX-4.2
from 8-K/A 25 pages CERo Therapeutics Holdings, Inc. (F/K/a Phoenix Biotech Acquisition Corp.) Warrant to Purchase Common Stock
12/34/56
EX-4.5
from 10-K 11 pages Phoenix Biotech Acquisition Corp. Description of Securities
12/34/56
EX-4.1
from 8-K 22 pages Warrant Agreement Between Phoenix Biotech Acquisition Corp. and Continental Stock Transfer & Trust Company Dated October 5, 2021
12/34/56
EX-4.2
from S-1/A 3 pages Phoenix Biotech Acquisition Corp. a Delaware Corporation Class a Common Stock
12/34/56
EX-4.1
from S-1/A 3 pages Phoenix Biotech Acquisition Corp. Units Consisting of One Share of Class a Common Stock and One-Half Warrant to Purchase One Share of Class a Common Stock
12/34/56
EX-4.4
from S-1 22 pages Warrant Agreement Between Phoenix Biotech Acquisition Corp. and Continental Stock Transfer & Trust Company Dated [●], 2021
12/34/56
EX-4.2
from S-1 3 pages Phoenix Biotech Acquisition Corp. a Delaware Corporation Class a Common Stock
12/34/56
EX-4.1
from S-1 3 pages Phoenix Biotech Acquisition Corp. Units Consisting of One Share of Class a Common Stock and One-Half Warrant to Purchase One Share of Class a Common Stock
12/34/56